期刊文献+

炔雌醇环丙孕酮片联合左炔诺孕酮宫内释放系统治疗排卵障碍性异常子宫出血的效果 被引量:7

Efficacy of Ethinyl Estradiol Cyproterone Tablets combined with levonorgestrel-releasing intrauterine system in the treatment of ovulatory abnormal uterine bleeding
在线阅读 下载PDF
导出
摘要 目的探讨炔雌醇环丙孕酮片联合左炔诺孕酮宫内释放系统(LNG-Ius)治疗排卵障碍性异常子宫出血的效果。方法选取2019年1月至2021年1月吉安市中心人民医院妇产科收治的160例排卵障碍性异常子宫出血患者作为研究对象,按照随机数字表法将其分为对照组(80例)与观察组(80例)。对照组患者采用LNG-Ius治疗,观察组患者采用炔雌醇环丙孕酮片联合LNG-Ius治疗。比较两组患者的临床治疗效果、月经失血评分及性激素水平。结果观察组患者的临床治疗总有效率高于对照组,差异有统计学意义(P<0.05)。两组患者治疗前的月经失血评分比较,差异无统计学意义(P>0.05);观察组患者治疗后的月经失血评分低于对照组,差异有统计学意义(P<0.05)。治疗前,两组患者的雌二醇(E_(2))、促黄体生成素(LH)、促卵泡生成素(FSH)水平比较,差异无统计学意义(P>0.05);治疗后,观察组患者的E_(2)、LH、FSH水平低于对照组,差异有统计学意义(P<0.05)。结论针对排卵障碍性异常子宫出血患者,采取炔雌醇环丙孕酮片联合LNG-Ius治疗有较佳的效果,可有效改善患者的性激素水平,利于患者病情的恢复。 Objective To investigate the effect of Ethinyl Estradiol Cyproterone Tablets combined with levonorgestrel-releasing intrauterine system(LNG-Ius)in the treatment of ovulatory abnormal uterine bleeding.Methods From January 2019 to January 2021,160 patients with ovulatory abnormal uterine bleeding who were admitted to the Department of Obstetrics and Gynecology of Ji′an Central People′s Hospital were selected as the research objects,they were divided into the control group(80 cases)and the observation group(80 cases)according to the random number table method.The control group was treated with LNG-Ius,and the observation group was treated with Ethinyl Estradiol Cyproterone Tablets combined with LNG-Ius.The clinical treatment effect,menstrual blood loss score and sex hormone levels were compared between the two groups.Results The total effective rate of clinical treatment in the observation group after treatment was higher than that in the control group,and the difference was statistically significant(P<0.05).There was no significant difference in the menstrual blood loss score between the two groups before treatment(P>0.05).The menstrual blood loss score in the observation group after treatment was lower than that in the control group,and the difference was statistically significant(P<0.05).Before treatment,there were no statistical differences in the levels of estradiol(E_(2)),luteinizing hormone(LH)and follicle-stimulating hormone(FSH)between the two groups(P>0.05).After treatment,the E_(2),LH and FSH levels of the observation group were lower than those of the control group,and the differences were statistically significant(P<0.05).Conclusion For patients with ovulatory abnormal uterine bleeding,the combination of Ethinyl Estradiol Cyproterone Tablets combined with LNG-Ius has a better therapeutic effect,which can effectively improve the level of sex hormones and is conducive to the recovery of the patients′condition.
作者 罗春艳 夏桥 陈虹 LUO Chunyan;XIA Qiao;CHEN Hong(Department of Obstetrics and Gynecology,Ji′an Central People′s Hospital,Jiangxi Province,Ji′an 343000,China;Department of Obstetrics and Gynecology,People′s Hospital of Yanshan County,Shangrao City,Jiangxi Province,Yanshan 334000,China)
出处 《中国当代医药》 CAS 2022年第27期100-103,共4页 China Modern Medicine
基金 江西省卫生健康委科技计划项目(202212823)。
关键词 炔雌醇环丙孕酮片 左炔诺孕酮宫内缓释系统 排卵障碍性异常子宫出血 性激素水平 Ethinyl Estradiol Cyproterone Tablets Levonorgestrel-releasing intrauterine system Ovulatory abnormal uterine bleeding Sex hormone level
  • 相关文献

参考文献18

二级参考文献231

  • 1徐萍.鲜益母草胶囊治疗经期延长[J].浙江中西医结合杂志,2004,14(12):771-772. 被引量:4
  • 2何淑明,张阳德.左旋炔诺酮宫內缓释系统治疗子宫腺肌病的临床研究[J].南方医科大学学报,2006,26(12):1794-1796. 被引量:11
  • 3韩玉芬,程淑蕊,敬文娜,张巧平.卵巢储备功能下降的预测及治疗[J].中国计划生育学杂志,2007,15(2):117-117. 被引量:147
  • 4Manzanares MA, Gomez - Palomares JL, Riceiareni E, et al. Triggering ovulation with gonadotropin - releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels. Fertility and Sterility,2010,93(4) :1215 - 1219.
  • 5Kahnberg A, Enskog A, Brannstrom M, et al. Prediction of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization. Acta Obstetrieia et Gynecologica Scandinavica ,2009,88 ( 12 ) : 1373 - 1381.
  • 6Smith LP, Hacker MR, Alper MM. Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive.outpatient transvaginal paracentesis. Fertility and Sterility, 2009,2 ( 6 ) : 1953 - 1959.
  • 7BeUver J, Pellicer A. Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome. Fertility and Sterility, 2009,92 (6) :1803 - 1810.
  • 8Vloeberghs V, Peeraer K, Pexsters A. Ovarian hyperstimulation syndrome and complications of ART. Best Practice and Research : Clinical Obstetrics and Gynaecology ,2009,23 ( 5 ) :691 - 709.
  • 9Prakash A, Karasu T, Mathur R. Ovarian hyperstimulation syndrome: pathophysiology, prevention and management. Obstetrics, Gynaecology and Reproductive Medicine, 2009, 19 (9) : 247 - 252.
  • 10Bonilla - Musoles FM, Raga F, Castillo JC. High doses of GnRH antagonists are efficient in the management of severe ovarian hyperstimulation syndrome. Clinical and Experimental Obstetrics and Gynecology,2009,36(2) :78 -81.

共引文献212

同被引文献90

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部